美国炎症性肠病少数民族和种族群体的 COVID-19 结局。
COVID-19 Outcomes Among Racial and Ethnic Minority Individuals With Inflammatory Bowel Disease in the United States.
机构信息
The Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York.
Division of Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
出版信息
Clin Gastroenterol Hepatol. 2021 Oct;19(10):2210-2213.e3. doi: 10.1016/j.cgh.2021.05.060. Epub 2021 Jun 2.
The coronavirus disease 2019 (COVID-19) has affected more than 29 million people and led to more than 542,000 deaths in the United States. Older age, comorbidities, and racial and ethnic minority status are associated with severe COVID-19. Among patients with inflammatory bowel disease (IBD), racial and ethnic minorities have worse outcomes, mediated in part by inequitable health care access. Racial and ethnic minority patients with IBD and COVID-19 may be an especially vulnerable population. The purpose of this study was to evaluate racial and ethnic disparities in COVID-19 outcomes among IBD patients and the impact of non-IBD comorbidities on observed disparities.
2019 年冠状病毒病（COVID-19）已影响超过 2900 万人，并导致美国超过 54.2 万人死亡。年龄较大、合并症以及种族和民族少数群体与严重的 COVID-19 有关。在炎症性肠病（IBD）患者中，少数族裔的结果更差，部分原因是医疗保健机会不平等。患有 IBD 和 COVID-19 的少数族裔患者可能是一个特别脆弱的群体。本研究的目的是评估 IBD 患者中 COVID-19 结局的种族和民族差异，以及非 IBD 合并症对观察到的差异的影响。
Zotero 插件